期刊文献+

玻璃体切除术后白内障发生或进展的机制及其影响因素 被引量:2

Mechanisms and influencing factors of cataract occurrence or progression after vitrectomy
下载PDF
导出
摘要 玻璃体切除术(pars plana vitrectomy,PPV)自1972年由O'Malley提出后已成为眼科治疗史的一大革命,打破了既往的手术禁区,为无数玻璃体视网膜疾病的患者带去了希望。随着玻璃体切除术的不断发展,其安全性及有效性增加,手术适应证扩大,目前玻璃体切除术已成为治疗眼后段疾病最常用的手术方式。虽然玻璃体切除术后并发症越来越少,但白内障的发生或进展仍为PPV术后最常见的高发并发症,严重影响患者术后视力及眼底的观察,且目前尚无有效办法预防,白内障摘除手术为其主要治疗方法,严重增加了患者的负担。PPV术后白内障进展的影响因素众多,对其发病机制有多种假说,包括晶状体周围氧分压增高、玻璃体正常结构的破坏、光毒性等,但尚无定论。本文将从PPV术后白内障发生或进展的发生率、发生机制、影响因素几方面对玻璃体切除术后白内障发生或进展进行综述,以期为其后续的研究及临床预防和治疗提供参考。 Since first proposed by O’Malley in 1972,the revolutionary vitrectomy has brought ophthalmic surgery into a new era,bringing hope to countless patients with vitreoretinal diseases.With the development of surgical techniques,increased safety and effectiveness,and expanded surgical indications,vitrectomy has become the most common surgical treatment for various posterior segment diseases.Though there is a trend of decreasing in postoperative complications,the occurrence and progression of cataract remains the most common complication after vitrectomy.As cataract would compromise the postoperative vision and fundus observation,cataract extraction surgery is always inevitable,which seriously increases the burden of patients.The pathogenesis of cataract is till inconclusive.There are currently many hypotheses including increased oxygen partial pressure around the lens,destruction of the vitreous structure,and phototoxicity.This article reviews the incidence,mechanism and influencing factors of cataract occurrence or progression after vitrectomy,aiming to provide more evidence for further investigation of pathogenesis,prevention and treatment for post-vitrectomy cataract.
作者 张妙 罗莉霞 Miao Zhang;Li-Xia Luo(State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China)
出处 《国际眼科杂志》 CAS 北大核心 2021年第12期2076-2080,共5页 International Eye Science
基金 国家自然科学基金项目(No.82070940)。
关键词 玻璃体切除术 白内障 机制 影响因素 vitrectomy cataract mechanism influencing factors
  • 相关文献

参考文献8

二级参考文献52

  • 1J.SEBAGMD,FACS, FCOphth. Thevitreous[A]. WILLIAN M. HART, Jr. Adler's physiology of the eye:clinical application. 9th ed copyright[M]. Mosby - Year Book, Inc. 1992,268 - 317.
  • 2Motohiro Kamei, M.D. Merits and demerits of silicone oil(SO) - Do you want SO to be injected? [J]. Nippon Ganka Gakkai Zasshi,2003,107 (8) :423 -424.
  • 3马志中.玻璃体生化和生理[A].张卯年 马志中.玻璃体显微手术学[M].北京:金盾出版社,1994.6-8.
  • 4王文吉.玻璃体生理生化[A].李凤鸣.眼科全书上册[M].北京:人民卫生出版社,1996.323-30.
  • 5.玻璃体病[A].惠延年.眼科学(第5版)[M].北京:人民卫生出版社,2001.138-144.
  • 6Kreiger AE.Wound complications in pars vitrectomy.Retina 1993;13:335-344
  • 7Sen J,Groenewald C,Hiscott PS,et al.Transretinal choroidal tumor biopsy with a 25-gauge vitrector.Ophthalmology 2006;113:1028-1031
  • 8Gonzales CR,Boshra J,Schwartz SD.25-Gauge pars plicata vitrectomy for
  • 9and 5 retinopathy of prematurity.Retina 2006;26:S42-464 Lam DS,Fan DS,Mohamed S,et al.25-gauge transconjunctive sutureless vitrectomy system in the surgical management of children with posterior capsular opacification.Clin Exp Ophthalmol 2005;33:495-498
  • 10Keshavamurthy R,Venkatesh P,Garg S.Ultrasound biomicroscopy findings of 25G Transconjunctival Sutureless(TSV) and conventional(20G) pars plana sclerotomy in the same patient.BMC Ophthalmol 2006;6:7

共引文献66

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部